CDMO Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys
Avid Bioservices, Inc. (CDMO) Investigation: Avid shares fell on Mar. 12, 2024 after the CDMO announced the need to restate its financial performance over several quarters in 2022 and 2023. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback